Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDDT vs AM-BQT for H. pylori Eradication
NCT03897244Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- May 2019
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started May 2019; status: completed.
02
Drugs
rabeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03897244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03897244.